Showing 1231-1240 of 1587 results for "".
- Internal Mammary Vessels Lead in Autologous Breast Reconstruction, Review Findshttps://modernaesthetics.com/news/internal-mammary-vessels-lead-in-autologous-breast-reconstruction-review-finds/2485836/Autologous breast reconstruction most commonly relies on free tissue transfer to achieve natural-appearing and aesthetically favorable outcomes. In a narrative review published in Gland Surgery, the authors examined recipient vessel selection strategies and their clinical implications in
- Photocurable Collagen Filler Aims to Address Weight-Loss–Associated Facial Deflationhttps://modernaesthetics.com/news/photocurable-collagen-filler-aims-to-address-weight-lossassociated-facial-deflation/2485851/CollPlant Biotechnologies announced the strategic positioning of its photocurable dermal filler platform to address facial volume loss associated with rapid weight reduction, including in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) for metabolic health and weight ma
- WiQo US Expands Midwest Footprint Through Exclusive Partnership With Synergy Aestheticshttps://modernaesthetics.com/news/wiqo-us-expands-midwest-footprint-through-exclusive-partnership-with-synergy-aesthetics/2485815/WiQo US announced a strategic partnership with Synergy Aesthetics, granting the organization exclusive rights to represent the WiQo PRX product system across a 10-state Midwest region. The agreement covers Arkansas, Iowa, Kansas, Minnesota, Missouri, Nebraska, Nort
- PRP Accelerates Hair Regrowth in Murine Model, Study Findshttps://modernaesthetics.com/news/prp-accelerates-hair-regrowth-in-murine-model-study-finds/2485767/Subcutaneous platelet-rich plasma (PRP) injections accelerated hair regrowth and increased Wnt10b expression in a murine model, according to a study published in Aesthetic Plastic Surgery. Investigators led by Guangyu Mao evaluated the effects of PRP on hair follicle cycling in 20
- Octane Aesthetics Tech Forum Panelists React to FDA Approval of Oral Semaglutidehttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-react-to-fda-approval-of-oral-semaglutide/2485572/At the 2026 Octane Aesthetics Tech Forum, panelists weighed in on the recent FDA approval of oral semaglutide, offering a mix of cautious optimism and clinical realism. While the approval marks a milestone in expanding GLP-1 receptor agonist (RA) access, most experts on the panel said oral versio
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Injectable Skin Boosters Market Set to Exceed $3.2 Billion by 2032, Driven by HA-Based Rejuvenation Trendshttps://modernaesthetics.com/news/injectable-skin-boosters-market-set-to-exceed-32-billion-by-2032-driven-by-ha-based-rejuvenation-trends/2485495/The global market for injectable skin boosters is projected to more than double over the next decade, climbing from $1,492.17 million in 2025 to an estimated $3,263.80 million by 2032, according to new data from MMR Statistics. This represents a compound annual gro
- AAFPRS President Outlines “Three Rs” of Facial Plastic Surgeryhttps://modernaesthetics.com/news/aafprs-president-outlines-three-rs-of-facial-plastic-surgery/2485394/As patient interest in facial aesthetic and reconstructive procedures continues to grow, the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is emphasizing the importance of specialty training through a new public education framework: the “Three Rs of the AAFPRS:” rhinoplas
- FDA Approves Once-Daily Oral Semaglutidehttps://modernaesthetics.com/news/fda-approves-once-daily-oral-semaglutide/2485258/The US Food and Drug Administration (FDA) has approved Novo Nordisk’s once-daily oral formulation of semaglutide, marketed as Wegovy® pill, marking the first oral GLP-1 receptor agonist approved for chronic weight management in the United States. The approval includes indications for adults with
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://modernaesthetics.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform